PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

Peer Review reports

Original Submission
18 Feb 2014	Submitted	Original manuscript
24 Feb 2014	Author responded	Author comments - Marwan Sabbagh
Resubmission - Version 2
24 Feb 2014	Submitted	Manuscript version 2
6 Mar 2014	Reviewed	Reviewer Report - Kurt Jellinger
23 Mar 2014	Reviewed	Reviewer Report - Valentina Garibotto
27 Mar 2014	Author responded	Author comments - Marwan Sabbagh
Resubmission - Version 3
27 Mar 2014	Submitted	Manuscript version 3
Publishing
31 Mar 2014	Editorially accepted
9 Apr 2014	Article published	10.1186/1471-2377-14-79

Back to article page